Agenus Inc (AGEN)
15.46
-0.54
(-3.38%)
USD |
NASDAQ |
Jun 14, 16:00
15.44
-0.02
(-0.13%)
After-Hours: 20:00
Agenus Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2009 | 16.90M |
| December 31, 2008 | 20.66M |
| December 31, 2007 | 21.79M |
| December 31, 2006 | 28.64M |
| December 31, 2005 | 47.08M |
| December 31, 2004 | 41.72M |
| Date | Value |
|---|---|
| December 31, 2003 | 46.26M |
| December 31, 2002 | 39.98M |
| December 31, 2001 | 31.36M |
| December 31, 2000 | 17.58M |
| December 31, 1999 | 11.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ligand Pharmaceuticals Inc | 24.54M |
| Artivion Inc | 28.71M |
| Bioventus Inc | 13.45M |
| AIM ImmunoTech Inc | 10.94M |
| Protalix BioTherapeutics Inc | 17.09M |